Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Alicante (19)

2024

  1. Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis

    The Lancet Microbe, Vol. 5, Núm. 1, pp. e43-e51

2023

  1. Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant

    Journal of Medical Virology, Vol. 95, Núm. 1

  2. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 279-284

  2. Justification for 24/7 clinical microbiology services

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Performance of a flow cytometry-based immunoassay for detection of antibodies binding to SARS-CoV-2 spike protein

    Scientific Reports, Vol. 12, Núm. 1

  4. Population-based sequencing of Mycobacterium tuberculosis reveals how current population dynamics are shaped by past epidemics

    eLife, Vol. 11

  5. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination

    Journal of Medical Virology, Vol. 94, Núm. 8, pp. 3776-3782

  6. SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection

    Journal of Medical Virology, Vol. 94, Núm. 9, pp. 4216-4223

  7. Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. e865-e868

  8. Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain

    Vaccine, Vol. 40, Núm. 41, pp. 5942-5949

2021

  1. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2019

  1. Adoption of new technologies in laboratory workflow practices for positive blood culture bottles: a cross-sectional survey among hospitals in the Autonomous Community of Valencia, Spain

    European Journal of Clinical Microbiology and Infectious Diseases

  2. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

  3. Missing cases of herpes simplex virus (HSV) infection of the central nervous system when the Reller criteria are applied for HSV PCR testing: A multicenter study

    Journal of Clinical Microbiology, Vol. 57, Núm. 2

2018

  1. A survey on practices for active surveillance of carriage of multidrug-resistant bacteria in hospitals in the Autonomous Community of Valencia, Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 37, Núm. 11, pp. 2069-2074

2017

  1. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

2015

  1. Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: An insight into current clinical practice

    Transplant International, Vol. 28, Núm. 9, pp. 1042-1054

2011

  1. Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: Results from the FUNGEMYCA study.

    Revista Iberoamericana de Micologia, Vol. 28, Núm. 2, pp. 91-99